Status:
COMPLETED
Enhancing the Prospective Prediction of Psychosis
Lead Sponsor:
Yale University
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Schizophrenia
Psychotic Disorders
Eligibility:
All Genders
12-35 years
Brief Summary
This study will gather information on the natural history of the basic symptoms of psychosis to identify factors that may affect the improvement or persistence of the symptoms.
Detailed Description
Psychosis is a serious mental condition in which a person momentarily loses contact with reality. People in a state of psychosis may experience hallucinations or delusional beliefs that make day-to-da...
Eligibility Criteria
Inclusion
- Meets modified criteria of prodromal syndromes (COPS) for schizophrenia prodrome or help-seeking control
Exclusion
- History of psychosis
- Antipsychotic treatment in the month prior to study entry
- More than 16 weeks of lifetime antipsychotic treatment
Key Trial Info
Start Date :
August 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
268 Patients enrolled
Trial Details
Trial ID
NCT00291200
Start Date
August 1 2003
End Date
February 1 2009
Last Update
June 10 2014
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Prevention through Risk Identification Management and Education (PRIME) Clinic
New Haven, Connecticut, United States, 06519
2
PRIME Clinic
Chapel Hill, North Carolina, United States, 27599
3
PRIME Clinic
Toronto, Ontario, Canada